Updating results

912 results for Women's health

Sort: Date | Relevance

Lesinurad for treating chronic hyperuricaemia in people with gout (TA506)

Evidence-based recommendations on lesinurad (Zurampic) for treating chronic hyperuricaemia (too much uric acid/urate in blood) in adults with gout

Technology appraisal guidance Published February 2018

Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (TA161)

Evidence-based recommendations on raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women

Technology appraisal guidance Published October 2008 Last updated February 2018

Intrabeam radiotherapy system for adjuvant treatment of early breast cancer (TA501)

Evidence-based recommendations on using Intrabeam radiotherapy during breast-conserving surgery for adults with early breast cancer

Technology appraisal guidance Published January 2018

Fulvestrant for untreated locally advanced or metastatic oestrogen-receptor positive breast cancer (TA503)

Evidence-based recommendations on fulvestrant (Faslodex) for untreated locally advanced or metastatic (secondary) oestrogen-receptor positive breast cancer in

Technology appraisal guidance Published January 2018

EpiFix for chronic wounds (MIB139)

Advice on the use of EpiFix (an allograft comprising dehydrated human amnion/chorion membrane tissue/dHACM) for chronic wounds to aid local decision-making

Medtech innovation briefing Published January 2018

Sore throat (acute): antimicrobial prescribing (NG84)

This guideline sets out an antimicrobial prescribing strategy for acute sore throat. It aims to limit antibiotic use and reduce antimicrobial resistance. Acute sore throat is often caused by a virus, lasts for about a week, and most people get better without antibiotics. Withholding antibiotics rarely leads to complications.

Antimicrobial prescribing guideline Published January 2018

MammaTyper in vitro diagnostic test for determining breast cancer subtypes (MIB135)

Advice on the use of the MammaTyper in vitro diagnostic test for determining breast cancer subtypes to aid local decision-making

Medtech innovation briefing Published January 2018

Plasma EGFR mutation tests for adults with locally advanced or metastatic non-small-cell lung cancer (MIB137)

Advice on the use of plasma EGFR mutation tests for adults with locally advanced or metastatic non-small-cell lung cancer (NSCLC) to aid local decision-making

Medtech innovation briefing Published January 2018

TYM smartphone otoscope for imaging and videoing the external ear canal and eardrum (MIB134)

Advice on the use of the TYM smartphone otoscope (using Apple iOS device) for imaging/videoing the external ear canal and eardrum to aid local decision-making

Medtech innovation briefing Published January 2018

Palbociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer (TA495)

Evidence-based recommendations on palbociclib (Ibrance) as initial endocrine-based therapy for hormone receptor-positive, HER2-negative, locally advanced or

Technology appraisal guidance Published December 2017

Ribociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer (TA496)

Evidence-based recommendations on ribociclib (Kisqali) as initial endocrine-based therapy for hormone-receptor positive, human epidermal growth factor receptor

Technology appraisal guidance Published December 2017

Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system) (DG14)

Evidence-based recommendations on point-of-care coagulometers (the CoaguChek XS system) to self-monitor blood clotting

Diagnostics guidance Published September 2014 Last updated December 2017

Point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease (MIB132)

Advice on the use of point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease

Medtech innovation briefing Published December 2017

Nivolumab for treating squamous cell carcinoma of the head and neck after platinum-based chemotherapy (TA490)

Evidence-based recommendations on nivolumab (Opdivo) for squamous cell carcinoma (SCC) of the head and neck in adults who have had platinum-based chemotherapy

Technology appraisal guidance Published November 2017

Trastuzumab emtansine for treating HER2-positive advanced breast cancer after trastuzumab and a taxane (TA458)

Evidence-based recommendations on trastuzumab emtansine (Kadcyla) for treating advanced HER2-positive breast cancer that has been treated before

Technology appraisal guidance Published July 2017 Last updated November 2017

Health app: GDm-Health for people with gestational diabetes (MIB131)

Advice on the GDm-Health app to remotely monitor blood glucose in people with gestational diabetes (diabetes in pregnancy) to aid local decision-making

Medtech innovation briefing Published November 2017

Health app: ChatHealth communication platform in school nursing services (MIB130)

Advice on the use of the ChatHealth app for anonymous and confidential communication between patients and healthcare professionals in school nursing services

Medtech innovation briefing Published November 2017

Health app: Sleepio for adults with poor sleep (MIB129)

Advice on the use of the Sleepio health app to help adults with poor sleep improve sleep through cognitive behavioural therapy, to aid local decision-making

Medtech innovation briefing Published November 2017

Radiation dose monitoring software for medical imaging with ionising radiation (MIB127)

Advice on the use of radiation dose monitoring software for medical imaging with ionising radiation to aid local decision-making

Medtech innovation briefing Published October 2017

Hepatitis B (chronic): diagnosis and management (CG165)

This guideline covers assessing and managing chronic hepatitis B in children, young people and adults. It aims to improve care for people with hepatitis B by specifying which tests and treatments to use for people of different ages and with different disease severities.

Clinical guideline Published June 2013 Last updated October 2017

Immunosuppressive therapy for kidney transplant in adults (TA481)

Evidence-based recommendations on immunosuppressive therapies for preventing kidney rejection in adults

Technology appraisal guidance Published October 2017

Immunisations for under 19s

Everything NICE has said on immunisation in under 19s in an interactive flowchart

NICE Pathway Published October 2011 Last updated October 2017

Child abuse and neglect (NG76)

This guideline covers recognising and responding to abuse and neglect in children and young people aged under 18. It covers physical, sexual and emotional abuse, and neglect. The guideline aims to help anyone whose work brings them into contact with children and young people to spot signs of abuse and neglect and to know how to respond. It also supports practitioners who carry out assessments and provide early help and interventions to children, young people, parents and carers.

NICE guideline Published October 2017

Thora-3Di for assessing asthma in children (MIB122)

Advice on the use of Thora-3Di for assessing asthma in children (paediatric) to aid local decision-making

Medtech innovation briefing Published October 2017

Memokath-028, 044 and 045 stents for urethral obstruction (MIB123)

Advice on the use of Memokath-028, 044 and 045 stents for urethral obstruction and bladder neck or outlet obstructions in men to aid local decision-making

Medtech innovation briefing Published October 2017

FreeStyle Libre for glucose monitoring (MIB110)

Advice on the use of FreeStyle Libre for monitoring glucose levels in diabetes to aid local decision-making

Medtech innovation briefing Published July 2017 Last updated September 2017

Farco-fill Protect for indwelling urinary catheterisation (MIB121)

Advice on the use of Farco-fill Protect for inflating Foley catheter balloons for indwelling (in-situ) urinary catheterisation to aid local decision-making

Medtech innovation briefing Published September 2017

Immunisations: reducing differences in uptake in under 19s (PH21)

This guideline covers increasing immunisation uptake among children and young people aged under 19 years in groups and settings where immunisation coverage is low. It aims to improve access to immunisation services and increase timely immunisation of children and young people. It also aims to ensure babies born to mothers infected with hepatitis B are immunised.

Public health guideline Published September 2009 Last updated September 2017

Caris Molecular Intelligence for guiding cancer treatment (MIB120)

Advice on the use of Caris Molecular Intelligence (CMI; solid tumour biomarker analysis service) for guiding cancer treatment to aid local decision-making

Medtech innovation briefing Published September 2017

Type 2 diabetes: prevention in people at high risk (PH38)

This guideline covers how to identify adults at high risk of type 2 diabetes. It aims to remind practitioners that age is no barrier to being at high risk of, or developing, the condition. It also aims to help them provide those at high risk with an effective and appropriate intensive lifestyle-change programme to prevent or delay the onset of type 2 diabetes. The recommendations in this guideline can be used alongside the NHS Health Check programme.

Public health guideline Published July 2012 Last updated September 2017

Sepsis: recognition, diagnosis and early management (NG51)

This guideline covers the recognition, diagnosis and early management of sepsis for all populations. The guideline committee identified that the key issues to be included were: recognition and early assessment, diagnostic and prognostic value of blood markers for sepsis, initial treatment, escalating care, identifying the source of infection, early monitoring, information and support for patients and carers, and training and education.

NICE guideline Published July 2016 Last updated September 2017

Aptiva for painful diabetic neuropathy (MIB119)

Advice on the use of Aptiva for painful diabetic neuropathy to aid local decision-making

Medtech innovation briefing Published September 2017

HIV testing: encouraging uptake (QS157)

This quality standard covers interventions to improve the uptake of HIV testing among people who may have undiagnosed HIV. It focuses on increasing testing to reduce undiagnosed infection in people at increased risk of exposure. It describes high-quality care in priority areas for improvement.

Quality standard Published September 2017

Look out for people at risk of having ADHD diagnosis missed, says NICE

NICE is urging doctors to think about a potential ADHD diagnosis in people who are at higher risk of having the condition, but who are usually overlooked.

News Published September 2017 Last updated September 2017

Endometriosis: diagnosis and management (NG73)

This guideline covers diagnosing and managing endometriosis. It aims to raise awareness of the symptoms of endometriosis, and to provide clear advice on what action to take when women with signs and symptoms first present in healthcare settings. It also provides advice on the range of treatments available.

NICE guideline Published September 2017

Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancer (TA476)

Evidence-based recommendations on paclitaxel as albumin-bound nanoparticles (nab-paclitaxel) for untreated metastatic pancreatic cancer in adults

Technology appraisal guidance Published September 2017

Fertility problems: assessment and treatment (CG156)

This guideline covers diagnosing and treating fertility problems. It aims to reduce variation in practice and improve the way fertility problems are investigated and managed.

Clinical guideline Published February 2013 Last updated September 2017

NICE says benefits of breast cancer drug fulvestrant too uncertain to make it cost effective

NICE has published draft guidance saying the evidence on using fulvestrant to treat a type of breast cancer does not prove it prolongs survival more than existing, less expensive treatments.

News Published September 2017 Last updated September 2017

Psoriasis: assessment and management (CG153)

This guideline covers assessing and managing psoriasis in adults, young people and children. It aims to improve long-term disease control and quality of life for people with psoriasis.

Clinical guideline Published October 2012 Last updated September 2017

Fungitell for antifungal treatment stratification (MIB118)

Advice on the use of the Fungitell assay for detecting fungal infections (pathogens, fungus, fungi) in guiding antifungal treatment to aid local decision-making

Medtech innovation briefing Published August 2017

Vitamin D: supplement use in specific population groups (PH56)

This guideline covers vitamin D supplement use. It aims to prevent vitamin D deficiency among specific population groups including infants and children aged under 4, pregnant and breastfeeding women, particularly teenagers and young women, people over 65, people who have low or no exposure to the sun and people with darker skin.

Public health guideline Published November 2014 Last updated August 2017

Vitamin D: supplement use in specific population groups

Everything NICE has said on preventing vitamin D deficiency in specific population groups in an interactive flowchart

NICE Pathway Published December 2014 Last updated August 2017

Liposuction for chronic lymphoedema (IPG588)

Evidence-based recommendations on liposuction for chronic lymphoedema in adults to remove build-up of fluid and excess fat tissue in limbs

Interventional procedures guidance Published August 2017

Advanced breast cancer: diagnosis and treatment (CG81)

This guideline covers care and support for people with advanced (stage 4) breast cancer. It aims to help them and their healthcare professionals make shared decisions about tests and treatments to improve outcomes and quality of life.

Clinical guideline Published February 2009 Last updated August 2017

Hepatitis B and C testing

Hepatitis B and C: ways to promote and offer testing to people at increased risk of infection.

NICE Pathway Published December 2012 Last updated August 2017

Pemetrexed for the maintenance treatment of non-small-cell lung cancer (TA190)

Evidence-based recommendations on pemetrexed disodium (Alimta) for the maintenance treatment of non-small-cell lung cancer (NSCLC)

Technology appraisal guidance Published June 2010 Last updated August 2017

Thousands more people could be offered drugs to prevent bone fractures because of osteoporosis

NICE has published new guidance on the use of drugs called bisphosphonates for preventing bone fractures in people at increased risk.

News Published August 2017 Last updated August 2017

Biopatch for venous or arterial catheter sites (MIB117)

Advice on the use of Biopatch hydrophilic foam dressing with chlorhexidine gluconate (CHG) for venous or arterial catheter sites to aid local decision-making

Medtech innovation briefing Published August 2017

Urethrotech UCD for difficult or failed catheterisation (MIB116)

Advice on the use of Urethrotech urethral catheterisation device (UCD) for difficult or failed catheterisations in men to aid local decision-making

Medtech innovation briefing Published August 2017

Domestic violence and abuse

Everything NICE has said on identifying, preventing and reducing domestic violence and abuse in an interactive flowchart

NICE Pathway Published February 2014 Last updated August 2017